Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Oral Mucositis Pain Treatments
Oral Mucositis Pain Treatments
The meta-analysis linked below examines oral mucositis pain treatments. Oral mucositis is a painful side effect in approximately 85% of ASCT patients. I developed a mild case of OM when I had my ASCT. I got off easy.
Though the study linked below talks about all chemotherapy-induced OM cases, regardless of the type of cancer, I am directing this post at MM patients considering an ASCT. OM is an excellent example of a side effect of ASCT that may not be an issue with novel therapies.
I will link to several blog posts below that provide information about oral mucositis prevention strategies.
- Oral Mucositis in Myeloma
- Oral Mucositis Therapies-
- Stem Cell Transplant Side Effects-MM-Oral Mucositis
- Another Mucositis Therapy for Myeloma
- Mucositis Cost Containment
How to manage Oral Mucositis from cancer treatment?
I am a long-term MM survivor and MM cancer coach. Experience has taught me that non-conventional therapies for OM can be just as, if not more effective, than conventional therapies for managing OM.
Email me at David.PeopleBeatingCancer@gmail.com to learn more about managing MM with both conventional and non-conventional therapies.
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Addressing Pain in Oral Mucositis: Narrative Review of Current Practices and Emerging Treatments
Objective: Oral mucositis (OM) is a debilitating complication of cancer therapies, affecting up to 85% of patients undergoing bone marrow transplantation and nearly all receiving head and neck radiotherapy.
Characterized by mucosal inflammation, ulceration, and severe pain, OM significantly impairs oral intake, speech, and quality of life. These disruptions, compounded by complications such as infection, bleeding, and increased healthcare costs, often necessitate treatment delays or modifications, negatively impacting cancer prognosis.
Recent insights into nociceptive and neuropathic mechanisms of OM-related pain have led to the development of innovative management strategies. Given the debilitating nature of OM in cancer patients and the critical need for effective pain control, this review aims to examine pharmacological advancements targeting the complex nature of OM-related pain, including agents such as:
- lidocaine,
- doxepin,
- benzydamine,
- methylene blue,
- opioids,
- gabapentin,
- palifermin,
- caphosol,
- and ketamine.
Methods: A literature search was conducted in the PUBMED, COCHRANE, and MEDLINE databases, covering studies from 2000 to 2024. Studies focusing on OM pathogenesis and pain management strategies were screened. Inclusion criteria encompassed randomized controlled trials, meta-analyses, and systematic reviews involving adult patients treated with lidocaine, doxepin, benzydamine, methylene blue, opioids, gabapentin, palifermin, caphosol, or ketamine for OM-associated pain.
Conclusion: OM pain arises from nociceptive and neuropathic pathways involving inflammatory cytokines and neuropeptides. Current interventions, including topical and systemic agents, have shown promise, yet variability in treatment protocols and limited high-quality evidence hinder standardized practices.
This review highlights the clinical applicability of emerging therapies, such as avasopasem manganese, which has demonstrated efficacy in mitigating OM progression. Ongoing clinical trials targeting novel pathways that modulate mucosal inflammatory response and limit disease severity offer hope for improved pain relief. Addressing the multifaceted nature of OM-associated pain is essential for enhancing quality of life and optimizing cancer treatment outcomes. Further research is needed to establish robust, evidence-based guidelines for OM pain management…
Conclusion
In conclusion, this review highlights the range of pharmacological and non-pharmacological interventions aimed at alleviating pain in OM. OM remains a significant complication of cancer therapy, with complex pathogenesis and substantial impact on patient quality of life. Enhanced pain management strategies are crucial, as they can reduce treatment delays, minimize dose reductions, and ultimately enhance therapeutic outcomes.
Additionally, effective management may lower healthcare costs by decreasing the need for supportive interventions and hospitalizations.
Given the complexity of OM pathogenesis and the diverse inflammatory mediators involved in pain perception, no single intervention has proven sufficient to address OM across its various stages.
Effective management often requires a combination of treatments, beginning with topical medications and escalating to systemic therapy. Despite the variety of available options, a well-established gold-standard protocol has yet to be defined.
Assessing the efficacy of mouthwashes for pain management presents challenges due to variations in their composition and concentration across clinical studies. This lack of standardization complicates the application of findings to clinical practice.
Certain mouthwashes, such as those containing lidocaine, doxepin, or benzydamine, have demonstrated promising results for pain relief. However, the potential benefits of combining different pain management strategies remain unclear.
Further clinical data are needed to determine whether such combinations could enhance pain reduction. Looking ahead, prioritizing research on novel molecular pathways—such as transient receptor potential (TRP) channels and neurotrophic factors—holds promise for the development of more targeted and effective therapies.”
oral mucositis pain treatments oral mucositis pain treatments oral mucositis pain treatments